Hepatitis C, metabolic syndrome, and inflammatory markers: Results from the Third National Health and Nutrition Examination Survey [NHANES III]

Diabetes Research and Clinical Practice

Volumn 75, Issue 3, 2007, Pages 320-326

  Shaheen, Magda ^a   Echeverry, Diana ^a   Oblad, Marcela Garcia ^a   Montoya, Marie I ^a   Teklehaimanot, Senait ^a   Akhtar, Abbasi J ^a  

^a CHARLES R DREW UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

Author keywords

Hepatitis C; Inflammatory markers; Metabolic syndrome

Indexed keywords

FERRITIN;

ADULT; AGED; ARTHRITIS; ARTICLE; BODY MASS; CONTRACEPTION; DEMOGRAPHY; DISEASE ASSOCIATION; FEMALE; GOUT; HEALTH SURVEY; HEPATITIS C; HUMAN; INFLAMMATION; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PROTEIN BLOOD LEVEL;

ADULT; BIOLOGICAL MARKERS; BODY MASS INDEX; CONTINENTAL POPULATION GROUPS; ETHNIC GROUPS; FEMALE; HEPATITIS C; HUMANS; INFLAMMATION; MALE; METABOLIC SYNDROME X; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; UNITED STATES;

EID: 33846114600     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2006.07.008     Document Type: Article

References (32)

1. Albright E., and Bell D. The liver, liver disease, and diabetes mellitus. The Endocrinologist 13 1 (2003) 58-66
2. Lauer G., and Bruce D. Hepatitis C virus infection. New Engl. J. Med. 345 1 (2001) 41-52
3. Allison M., Palmer C., and Alexander G. Evidence for a link between hepatitis C infection and diabetes mellitus in a cirrhotic population. J. Hepatol. 21 (1994) 1135-1139
4. Virseda I., Jaqueti J., Nicolas M., Prieto R., Somoza M., and Navarro F. Hepatitis C virus and type-2 diabetes mellitus. Is there a connection?. Enferm. Infecc. Microbiol. Clin. 20 2 (2002) 96-97
5. Thuluvath P., and John P. Association between hepatitis C, diabetes mellitus, and race. Am. J. Gastroenterol. 98 2 (2003) 438-441
6. Soma J., Taguma Y., Chiba S., Sato H., Sugimura K., Ogawa S., et al. High prevalence and adverse effect of hepatitis C virus infection in type II diabetic-related nephropathy. J. Am. Soc. Nephrol. 11 4 (2000) 690-699
7. Sangiorgio L., Attardo T., Gangemi R., Rubino C., Barone M., and Lunetta M. Increased frequency of HCV and HBV infection in type 2 diabetic patients. Diabetes Res. Clin. Pract. 48 2 (2000) 147-151
8. Qureshi H., Ahsan T., Mujeeb S., Jawad F., Mehdi I., Ahmed W., et al. Diabetes mellitus is equally frequent in chronic HCV and HBV infection. J. Pak. Med. Assoc. 52 7 (2002) 280-283
9. Mehta S., Brancati F., Sulkowski M., Strathdee S., Szklo M., and Thomas D. Prevalence of type 2 diabetes mellitus among persons with hepatitis C virus infection in the United States, letter to the editor. Hepatology 33 6 (2001) 1554
10. Mehta S., Brancati F., Strathdee S., Pankow J., Netski D., Coresh J., et al. Hepatitis C virus infection and incident type 2 diabetes. Hepatology 38 1 (2003) 50-56
11. Caronia S., Taylor S.K., Pagliaro L., Carr C., Palazzo U., Petrik J., et al. Further evidence for an association between non-insulin-dependent diabetes mellitus and chronic hepatitis C virus infection. Hepatology 30 4 (1999) 1059-1063
12. Mason J., Lau N., Hoang K., Qian G., Alexander L., Xu L., et al. Association of diabetes mellitus and chronic hepatitis C virus infection. Hepatology 29 2 (1999) 328-333
13. Strassburg C., Obermayer-Straub P., and Manns M. Autoimmunity in hepatitis C and D virus infection. J. Viral. Hepat. 3 2 (1996) 49-59
14. Ramji A., and Yoshida E. Diabetes mellitus after liver transplantation: another extrahepatic manifestation of hepatitis C. Can. J. Gastroenterol. 15 7 (2001) 432
15. Mitchell R., and Cotran R. Acute and chronic inflammation. In: Kumar C.R., and Robbins S.L. (Eds). Robbins Basic Pathology (2003), Elsevier Science, Philadelphia 33-59
16. Maeno T., Okumura A., Ishikawa T., Kato K., Sakakibara F., Sato K., et al. Mechanisms of increased insulin resistance in non-cirrhotic patients with chronic hepatitis C virus infection. J. Gastroenterol. Hepatol. 18 12 (2003) 1358-1363
17. Yudkin J., Stehouwer C., Emeis J., and Coppack S. C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue?. Arterioscler. Thromb. Vasc. Biol. 19 4 (1999) 972-978
18. Hotamisligil G., Peraldi P., Budavari A., Ellis R., White M., and Spiegelman B. IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance. Science 271 5249 (1996) 665-668
19. Hui J., Sud A., Farrell G., Bandara P., Byth K., Kench J., et al. Insulin resistance is associated with chronic hepatitis C virus infection and fibrosis progression. Gastroenterology 125 (2003) 1695-1704
20. Park Y., Zhu S., Palaniappan L., Heshka S., Carnethon M., and Heymsfield S. The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994. Arch. Inter. Med. 163 4 (2003) 427-436
21. Martin-Lazaro J., and Becerra-Fernandez A. The metabolic syndrome: uncertain criteria. Pharmacol. Res. 51 4 (2005) 387-389
22. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final Report, Circulation, 106 (25) (2002) 3143-31421.
23. Ford E., Giles H., and Mokdad A. Increasing prevalence of the metabolic syndrome among U.S. adults. Diabetes Care 27 10 (2004) 2444-2449
24. Ford E. The metabolic syndrome and C-reactive protein, fibrinogen, and leukocyte count: findings from the Third National Health and Nutrition Examination Survey. Atherosclerosis 168 (2003) 351-358
25. Jehn M., Clark J., and Guallar E. Serum ferritin and risk of the metabolic syndrome in U.S. adults. Diabetes Care 27 (2004) 2422-2428
26. Centers for Disease Control and Prevention, The Third National Health and Nutrition Examination Survey (NHANES III 1988-1994) (1996).
27. Liangpunsakul S., and Naga C. Relationship between hepatitis C and microalbuminuria: results from the NHANES III. Kidney Int. 67 (2005) 285-290
28. Ford E., Giles W., and Dietz W. Prevalence of the metabolic syndrome among US adults. JAMA 287 3 (2002) 356-359
29. Maeno T., Ishikawa T., Kato K., Sakakibara F., Sato K., Ayada M., et al. Mechanisms of increased insulin resistance in non-cirrhotic patients with chronic hepatitis C virus infection. J. Gastroenterol. Hepatol. 18 (2003) 1358-1363
30. Snehalatha C., Viswanathan V., and Ramachandran A. Cutoff values for normal anthropometric variables in Asian Indian adults. Diabetes Care 26 (2003) 1380-1384
31. Fernandez-Real J., Ricart-Engel W., Arroyo E., et al. Serum ferritin as a component of the insulin resistance syndrome. Diabetes Care 21 (1998) 62-68
32. Chen J., Wildman R., Hamm L., et al. Association between inflammation and insulin resistance in U.S. non-diabetic adults: results from the Third National Health and Nutrition Examination Survey. Diabetes Care 27 (2004) 2960-2965